📣 VC round data is live. Check it out!
- Public Comps
- Andiamo
Andiamo Valuation Multiples
Discover revenue and EBITDA valuation multiples for Andiamo and similar public comparables like INVO Fertility, Massmedica, Milton Essex, Nuwellis and more.
Andiamo Overview
About Andiamo
Andiamo Corp through its subsidiary is a technology company focused on development and distribution of mid-market smartphone devices equipped with a proprietary software ecosystem. Its smartphones are equipped with a cincluding a proprietary Android Operating System skin, and the number of proprietary mobile apps.
Founded
2000
HQ

Employees
1
Website
Financials (FY)
EV
$3M
Valuation Multiples
Start free trialAndiamo Stock Performance
Andiamo has current market cap of $3M, and enterprise value of $3M.
Andiamo's stock price is $0.00.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3M | $3M | 0.0% | — | — | — | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAndiamo Valuation Multiples
Andiamo Financial Valuation Multiples
As of May 10, 2026, Andiamo has market cap of $3M and EV of $3M.
| LTM | Last FY | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Andiamo Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Andiamo Competitors
Andiamo competitors include INVO Fertility, Massmedica, Milton Essex, Nuwellis, SpectraCure, VibroSense Dynamics, Lifeline Biotechnologies, Modne Zakupy, PExA and Telemedycyna Polska.
Most Andiamo public comparables operate across 3D Printing, Medical Devices, Telemedicine & Virtual Care, DeepTech, Industry 4.0, BioTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.4x | 1.9x | (2.2x) | (6.0x) | |||
| 0.6x | — | 10.2x | — | |||
| 16.5x | — | 25.2x | — | |||
| 0.3x | 0.2x | (0.3x) | — | |||
| — | — | (0.7x) | — | |||
| 10.1x | — | (4.7x) | — | |||
| — | — | — | — | |||
| 1230.4x | — | (16.0x) | — | |||
This data is available for Pro users. Sign up to see all Andiamo competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Andiamo
| When was Andiamo founded? | Andiamo was founded in 2000. |
| Where is Andiamo headquartered? | Andiamo is headquartered in United States. |
| How many employees does Andiamo have? | As of today, Andiamo has over 1 employees. |
| Is Andiamo publicly listed? | Yes, Andiamo is a public company listed on OTC Pink Sheets. |
| What is the stock symbol of Andiamo? | Andiamo trades under ANDI ticker. |
| When did Andiamo go public? | Andiamo went public in 2004. |
| Who are competitors of Andiamo? | Andiamo main competitors include INVO Fertility, Massmedica, Milton Essex, Nuwellis, SpectraCure, VibroSense Dynamics, Lifeline Biotechnologies, Modne Zakupy, PExA, Telemedycyna Polska. |
| What is the current market cap of Andiamo? | Andiamo's current market cap is $3M. |
| Is Andiamo profitable? | No, Andiamo is not profitable. |
| How many companies Andiamo has acquired to date? | Andiamo hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Andiamo has invested to date? | Andiamo hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Andiamo
Lists including Andiamo
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.